Establishment of KRAS G12C mutant patient-derived xenograft (PDX) models for pre-clinical evaluation of KRAS G12C targeted anticancer therapy.

被引：0
|
作者：
Shi, Wenting [1 ]
Tang, Xuzhen [2 ]
Zhang, Jingying [1 ]
Kuang, Xinhong [1 ]
Zhang, Yan [1 ]
Wang, Jingjing [1 ]
Gu, Qingyang [1 ]
Ji, Qunsheng [2 ]
机构：
[1] WuXi AppTec Suzhou Co Ltd, Suzhou, Peoples R China
[2] WuXi AppTec Shanghai Co Ltd, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3004
引用
收藏
页数：2
相关论文
共 50 条
  • [41] KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal Cancer
    Xiao, Annie
    Fakih, Marwan
    CLINICAL COLORECTAL CANCER, 2024, 23 (03) : 199 - 206
  • [42] KRAS G12C Mutations in NSCLC: From Target to Resistance
    Addeo, Alfredo
    Banna, Giuseppe Luigi
    Friedlaender, Alex
    CANCERS, 2021, 13 (11)
  • [43] Overcoming resistance to KRAS G12C inhibitors in lung cancer
    Ambrogio, Chiara
    CANCER SCIENCE, 2023, 114 : 987 - 987
  • [44] Expanding the Arsenal of Clinically Active KRAS G12C Inhibitors
    Arbour, Kathryn C.
    Lito, Piro
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2609 - +
  • [45] Diverse alterations associated with resistance to KRAS(G12C) inhibition
    Zhao, Yulei
    Murciano-Goroff, Yonina R.
    Xue, Jenny Y.
    Ang, Agnes
    Lucas, Jessica
    Mai, Trang T.
    Da Cruz Paula, Arnaud F.
    Saiki, Anne Y.
    Mohn, Deanna
    Achanta, Pragathi
    Sisk, Ann E.
    Arora, Kanika S.
    Roy, Rohan S.
    Kim, Dongsung
    Li, Chuanchuan
    Lim, Lee P.
    Li, Mark
    Bahr, Amber
    Loomis, Brian R.
    de Stanchina, Elisa
    Reis-Filho, Jorge S.
    Weigelt, Britta
    Berger, Michael
    Riely, Gregory
    Arbour, Kathryn C.
    Lipford, J. Russell
    Li, Bob T.
    Lito, Piro
    NATURE, 2021, 599 (7886) : 679 - +
  • [46] Breaking barriers: the latest insights into KRAS G12C inhibitors
    Attieh, Fouad
    Kourie, Hampig Raphael
    FUTURE ONCOLOGY, 2024, 20 (35) : 2685 - 2688
  • [47] KRAS G12C inhibition with sotorasib in metastatic colorectal cancer
    Severi, Christophe
    Van Cutsem, Eric
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (08) : 2792 - 2795
  • [48] Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C
    Zeng, Mei
    Lu, Jia
    Li, Lianbo
    Feru, Frederic
    Quan, Chunshan
    Gero, Thomas W.
    Ficarro, Scott B.
    Xiong, Yuan
    Ambrogio, Chiara
    Paranal, Raymond M.
    Catalano, Marco
    Shao, Jay
    Wong, Kwok-Kin
    Marto, Jarrod A.
    Fischer, Eric S.
    Janne, Pasi A.
    Scott, David A.
    Westover, Kenneth D.
    Gray, Nathanael S.
    CELL CHEMICAL BIOLOGY, 2017, 24 (08): : 1005 - +
  • [49] KRAS G12C Inhibitors: New Drugs, A New Hope
    Singhal, Surbhi
    Schokrpur, Shiruyeh
    Gandara, David
    Riess, Jonathan W.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (12) : 1594 - 1598
  • [50] Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation
    Chen, Yuxi
    Hua, Chen
    Lin, Xiaoxi
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (13): : 1259 - 1260
12345